156 related articles for article (PubMed ID: 29241349)
1. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Roshdy O; Pehr K; Sasseville D; Litvinov IV
J Cutan Med Surg; 2018; 22(2):154-165. PubMed ID: 29241349
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
3. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Habel Y; Risser DR; Gangar P; Jennings MA; Pehr K; Prieto VG; Sasseville D; Duvic M
Cancer; 2015 Jun; 121(12):1993-2003. PubMed ID: 25728286
[TBL] [Abstract][Full Text] [Related]
4. Incidence and mortality trends and geographic patterns of follicular lymphoma in Canada.
Le M; Ghazawi FM; Alakel A; Netchiporouk E; Rahme E; Zubarev A; Powell M; Moreau L; Roshdy O; Glassman SJ; Sasseville D; Popradi G; Litvinov IV
Curr Oncol; 2019 Aug; 26(4):e473-e481. PubMed ID: 31548815
[TBL] [Abstract][Full Text] [Related]
5. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Moreau JF; Buchanich JM; Geskin JZ; Akilov OE; Geskin LJ
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046454
[TBL] [Abstract][Full Text] [Related]
6. Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.
Clough L; Bayakly AR; Ward KC; Khan MK; Chen SC; Lechowicz MJ; Flowers CR; Allen PB; Switchenko JM
Cancer; 2020 Apr; 126(8):1700-1707. PubMed ID: 31943154
[TBL] [Abstract][Full Text] [Related]
7. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.
Litvinov IV; Tetzlaff MT; Rahme E; Jennings MA; Risser DR; Gangar P; Netchiporouk E; Moreau L; Prieto VG; Sasseville D; Duvic M
Cancer Med; 2015 Sep; 4(9):1440-7. PubMed ID: 26136403
[TBL] [Abstract][Full Text] [Related]
8. Geographic clustering of cutaneous T-cell lymphoma in New Jersey: an exploratory analysis using residential histories.
Henry KA; Wiese D; Maiti A; Harris G; Vucetic S; Stroup AM
Cancer Causes Control; 2021 Sep; 32(9):989-999. PubMed ID: 34117957
[TBL] [Abstract][Full Text] [Related]
9. Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada.
Le M; Ghazawi FM; Rahme E; Alakel A; Netchiporouk E; Savin E; Zubarev A; Glassman SJ; Sasseville D; Popradi G; Litvinov IV
Cancer; 2019 Nov; 125(22):3953-3959. PubMed ID: 31381139
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
Criscione VD; Weinstock MA
Arch Dermatol; 2007 Jul; 143(7):854-9. PubMed ID: 17638728
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study.
Tsang M; Le M; Ghazawi FM; Cyr J; Alakel A; Rahme E; Lagacé F; Netchiporouk E; Moreau L; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Popradi G; Litvinov IV
Cancer; 2019 Jul; 125(14):2435-2444. PubMed ID: 30951209
[TBL] [Abstract][Full Text] [Related]
12. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.
Ghazawi FM; Darwich R; Le M; Rahme E; Zubarev A; Moreau L; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
Br J Ophthalmol; 2019 Dec; 103(12):1872-1876. PubMed ID: 30819691
[TBL] [Abstract][Full Text] [Related]
13. Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.
Cattelan L; Ghazawi FM; Le M; Savin E; Zubarev A; Lagacé F; Sasseville D; Waschke K; Litvinov IV
Curr Oncol; 2020 Jun; 27(3):e294-e306. PubMed ID: 32669936
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
Semenov YR; Rosenberg AR; Herbosa C; Mehta-Shah N; Musiek AC
Br J Dermatol; 2020 Jan; 182(1):190-196. PubMed ID: 30920642
[TBL] [Abstract][Full Text] [Related]
15. Investigation of incidence and geographic distribution of gliomas in Canada from 1992 to 2010: a national population-based study highlighting the importance of exposure to airport operations.
Ji X; Alakel A; Ghazawi FM; Tsang M; Zubarev A; Lasry OJ; Litvinov IV
Front Oncol; 2023; 13():1190366. PubMed ID: 37260971
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Cutaneous T-Cell Lymphoma Incidence by Race/Ethnicity and Area-Based Socioeconomic Status.
Wiese D; Stroup AM; Shevchenko A; Hsu S; Henry KA
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834276
[TBL] [Abstract][Full Text] [Related]
17. Changing incidence trends of cutaneous T-cell lymphoma.
Korgavkar K; Xiong M; Weinstock M
JAMA Dermatol; 2013 Nov; 149(11):1295-9. PubMed ID: 24005876
[TBL] [Abstract][Full Text] [Related]
18. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
19. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
20. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL).
Ghazawi FM; Alghazawi N; Le M; Netchiporouk E; Glassman SJ; Sasseville D; Litvinov IV
Front Oncol; 2019; 9():300. PubMed ID: 31106143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
